These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23386922)

  • 21. [Securing the sustainability of biobanks].
    Kirsten R; Hummel M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):390-5. PubMed ID: 26769112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving Academic Biobank Value and Sustainability Through an Outputs Focus.
    Rush A; Catchpoole DR; Ling R; Searles A; Watson PH; Byrne JA
    Value Health; 2020 Aug; 23(8):1072-1078. PubMed ID: 32828220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Business Planning for a Campus-Wide Biobank.
    Tarling TE; Lasser F; Carter C; Matzke LA; Dhugga G; Arora N; Dee S; LeBlanc J; Babinsky S; O'Donoghue S; Cheah S; Watson P; Vercauteren SM
    Biopreserv Biobank; 2017 Feb; 15(1):37-45. PubMed ID: 28151006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of international biobanks and networks: success factors and key benchmarks.
    Vaught J; Kelly A; Hewitt R
    Biopreserv Biobank; 2009 Sep; 7(3):143-50. PubMed ID: 24835880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biospecimen Complexity-the Next Challenge for Cancer Research Biobanks?
    Watson PH
    Clin Cancer Res; 2017 Feb; 23(4):894-898. PubMed ID: 27551001
    [No Abstract]   [Full Text] [Related]  

  • 26. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Market-driven production of biospecimens and the role of NHS hospital-led biobanks.
    Timmons S; Vezyridis P
    Sociol Health Illn; 2017 Sep; 39(7):1242-1257. PubMed ID: 28555937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to Make a Cost Model for the Birth Cohort Biobank in China.
    Wu M; Wu D; Hu C; Yan C
    Front Public Health; 2020; 8():24. PubMed ID: 32154203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Levels Of Capitation Payments Needed To Shift Primary Care Toward Proactive Team And Nonvisit Care.
    Basu S; Phillips RS; Song Z; Bitton A; Landon BE
    Health Aff (Millwood); 2017 Sep; 36(9):1599-1605. PubMed ID: 28874487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer donor preferences for disposition of their biospecimens after biobank closure.
    Allen SC; Dixon MD; Switchenko JM; Pentz RD
    Cancer; 2017 Dec; 123(23):4648-4652. PubMed ID: 28746751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biobank Finances: A Socio-Economic Analysis and Review.
    Gee S; Oliver R; Corfield J; Georghiou L; Yuille M
    Biopreserv Biobank; 2015 Dec; 13(6):435-51. PubMed ID: 26697914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How Biobanks Are Assessing and Measuring Their Financial Sustainability.
    Brown T; Kelly DD; Vercauteren SM; Wilson WH; Werner A
    Biopreserv Biobank; 2017 Feb; 15(1):65-71. PubMed ID: 27869475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current practices for access, compensation, and prioritization in biobanks. Results from an interview study.
    Langhof H; Kahrass H; Illig T; Jahns R; Strech D
    Eur J Hum Genet; 2018 Nov; 26(11):1572-1581. PubMed ID: 30089824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The challenge of sustaining a hospital-based biobank and core molecular laboratory: the Beaumont experience.
    Wilson GD; D'Angelo K; Pruetz BL; Geddes TJ; Larson DM; Akervall J
    Biopreserv Biobank; 2014 Oct; 12(5):306-11. PubMed ID: 25314610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A contribution for cost models in biobanking.
    Huttin C; Stubbs A
    Technol Health Care; 2016; 24(1):93-8. PubMed ID: 26757438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An economic analysis of managed fee-for-service and direct reimbursement.
    van der Wal CJ; Smithwick CL
    J Am Coll Dent; 1997; 64(3):28-36. PubMed ID: 9420385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of a cost-accounting model in a biobank: practical implications.
    Gonzalez-Sanchez MB; Lopez-Valeiras E; García-Montero AC
    Pathobiology; 2014; 81(5-6):286-297. PubMed ID: 25792217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population issues in economic planning: uses of demography in business.
    Graham RJ
    J Aust Popul Assoc; 1984; 1():82-8. PubMed ID: 12267176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biobanking and the further development of precision medicine].
    Dahl E
    Pathologe; 2018 Jul; 39(4):308-312. PubMed ID: 29876651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.